This webpage provides general information to patients about pulmonary embolism and assists health care providers in identifying patients with PE at low risk of early mortality as well as long term follow up, optimal duration of therapy and thrombophilia testing recommendations. It also provides information on assistance with obtaining prior authorization and other resources for anticoagulants. The site is a resource of the Society for Vascular Medicine thanks to support from Janssen Pharmaceuticals.
PULMONARY EMBOLISM
Diagnosis and Treatment Pathway for Low Risk Pulmonary Embolism
